Purchase Order 75N91019P00140
Award Date 2/26/19
Potential Completion Date 2/29/24
Potential Value $213K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD) to acquire a BD FACSymphony A3 flow cytometer analyzer, a five-laser, 23-color system. The contract, which did not have a set-aside designation, was awarded on September 20, 2019 with a completion date of January 20, 2020 and a potential value of $359,443.75. BD Biosciences, a division of BD focused on...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $328,321.19 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of one BD BIO FACSYMPHANY A3 Analyzer. The place of performance is San Jose, California and the period of performance is from August 8, 2022 through December 6, 2022. Becton, Dickinson And Company BD Biosciences, Systems And Reagents...
- This is a $93,978.96 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on a BD FACSymphony A5 flow cytometer and associated instrumentation. The contract is for a base period ending on March 31, 2024, with no set-aside designation. The contract was awarded without competition under simplified acquisition procedures for commercial items, as the NCI...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Becton, Dickinson and Company's IDS division, operating as BD Diagnostic Systems. The $698,027.48 firm fixed price purchase order was awarded on August 29, 2018 to provide a BD Biosciences FACSymphony, or equal, fluorescent analytical flow cytometer. This equipment is being procured to support the National Cancer Institute's research programs. The...
- This firm fixed price contract for $24,896.80 was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Becton, Dickinson and Company for equipment. The prime contractor is BD Biosciences, a division of Becton, Dickinson and Company focused on providing instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. The place of...
- This is a $1,994,840.77 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The contract is for maintenance services on various government-owned BD flow cytometry equipment over the base period ending on July 1, 2026. BD is a global medical technology company that specializes in flow cytometry, cell imaging, and...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $402,814.00 firm fixed price purchase order to Becton, Dickinson and Company (BD) for the procurement of a BD LSRFortessa flow cytometer. This was a special order system, and the contract did not have a set-aside designation. BD is a manufacturer and supplier of medical devices, instruments, reagents, and related products to healthcare institutions, clinical laboratories,...
- This contract award to Becton, Dickinson and Company (BD) was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The $549,698.74 firm fixed-price purchase order is for the FACSymphony flow cytometer and associated components, including lasers, detectors, and consumables, to support biomedical research programs at NIH facilities. The award was made through simplified acquisition...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a purchase order to Becton, Dickinson and Company, operating through its IDS division (doing business as BD Diagnostic Systems), for the maintenance of a government-owned BD LSRII flow cytometry system. The firm-fixed-price contract has a potential value of $101,685.60 and a completion date of June 5, 2022. The contract does not have a set-aside designation. Becton, Dickinson and Company...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD) for a maintenance agreement on a FACS Celesta flow cytometer with a high throughput sampler. The potential value of the contract is $24,444.00, with a completion date of August 23, 2020. BD is a global medical technology company that provides instruments, reagents, and services for...